99 related articles for article (PubMed ID: 14608620)
1. Synthesis and physicochemical characteristics of a liver-targeted conjugate of fluorodeoxyuridine monophosphate with lactosaminated human albumin.
Di Stefano G; Tubaro M; Lanza M; Boga C; Fiume L; Traldi P
Rapid Commun Mass Spectrom; 2003; 17(22):2503-7. PubMed ID: 14608620
[TBL] [Abstract][Full Text] [Related]
2. Lactosaminated human albumin, a hepatotropic carrier of drugs.
Fiume L; Di Stefano G
Eur J Pharm Sci; 2010 Jul; 40(4):253-62. PubMed ID: 20403430
[TBL] [Abstract][Full Text] [Related]
3. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
Di Stefano G; Fiume L; Baglioni M; Busi C; Bolondi L; Farina C; Mori F; Chieco P; Pariali M; Kratz F; Molin L; Salmaso S; Caliceti P
Eur J Pharm Sci; 2008 Feb; 33(2):191-8. PubMed ID: 18201877
[TBL] [Abstract][Full Text] [Related]
5. Coupling of 5-fluoro 2'-deoxyuridine to lactosaminated poly-l-lysine: an approach to a regional, non-invasive chemotherapy of liver micrometastases.
Di Stefano G; Busi C; Camerino A; Derenzini M; Trerè D; Fiume L
Biochem Pharmacol; 2001 Feb; 61(4):459-65. PubMed ID: 11226380
[TBL] [Abstract][Full Text] [Related]
6. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
Franssen EJ; Jansen RW; Vaalburg M; Meijer DK
Biochem Pharmacol; 1993 Mar; 45(6):1215-26. PubMed ID: 8466542
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy.
Boga C; Fiume L; Baglioni M; Bertucci C; Farina C; Kratz F; Manerba M; Naldi M; Di Stefano G
Eur J Pharm Sci; 2009 Oct; 38(3):262-9. PubMed ID: 19695327
[TBL] [Abstract][Full Text] [Related]
8. Floxuridine coupling with lactosaminated human albumin to increase drug efficacy on liver micrometastases.
Di Stefano G; Busi C; Fiume L
Dig Liver Dis; 2002 Jun; 34(6):439-46. PubMed ID: 12132792
[TBL] [Abstract][Full Text] [Related]
9. Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin: identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry.
Alvarez-Sánchez R; Divkovic M; Basketter D; Pease C; Panico M; Dell A; Morris H; Lepoittevin JP
Chem Res Toxicol; 2004 Sep; 17(9):1280-8. PubMed ID: 15377163
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2'-deoxyuridine and 5-fluoro-2'-deoxyuridine derivatives and evaluation in antibody targeting studies.
Henn TF; Garnett MC; Chhabra SR; Bycroft BW; Baldwin RW
J Med Chem; 1993 May; 36(11):1570-9. PubMed ID: 8496926
[TBL] [Abstract][Full Text] [Related]
11. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
[TBL] [Abstract][Full Text] [Related]
12. Conjugates of nucleoside analogs with lactosaminated human albumin to selectively increase the drug levels in liver blood: requirements for a regional chemotherapy.
Di Stefano G; Lanza M; Busi C; Barbieri L; Fiume L
J Pharmacol Exp Ther; 2002 May; 301(2):638-42. PubMed ID: 11961068
[TBL] [Abstract][Full Text] [Related]
13. Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes.
Jansen RW; Kruijt JK; van Berkel TJ; Meijer DK
Hepatology; 1993 Jul; 18(1):146-52. PubMed ID: 7686877
[TBL] [Abstract][Full Text] [Related]
14. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate.
Di Stefano G; Lanza M; Kratz F; Merina L; Fiume L
Eur J Pharm Sci; 2004 Dec; 23(4-5):393-7. PubMed ID: 15567293
[TBL] [Abstract][Full Text] [Related]
15. Structural determination of the conjugate of human serum albumin with a mitomycin C derivative, KW-2149, by matrix-assisted laser desorption/ionization mass spectrometry.
Yasuzawa T; Tomer KB
Bioconjug Chem; 1997; 8(3):391-9. PubMed ID: 9177846
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin-protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromolecules.
Absar S; Nahar K; Choi S; Ahsan F; Yang VC; Kwon YM
J Biomed Mater Res A; 2014 Aug; 102(8):2481-90. PubMed ID: 23946132
[TBL] [Abstract][Full Text] [Related]
17. Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor.
Fiume L; Di Stefano G; Busi C; Mattioli A; Bonino F; Torrani-Cerenzia M; Verme G; Rapicetta M; Bertini M; Gervasi GB
J Viral Hepat; 1997; 4(6):363-70. PubMed ID: 9430355
[TBL] [Abstract][Full Text] [Related]
18. Enhanced liver targeting of 5-fluorouracil using galactosylated human serum albumin as a carrier molecule.
Cai C; Zhou K; Wu Y; Wu L
J Drug Target; 2006 Feb; 14(2):55-61. PubMed ID: 16608732
[TBL] [Abstract][Full Text] [Related]
19. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Wa C; Cerny RL; Clarke WA; Hage DS
Clin Chim Acta; 2007 Oct; 385(1-2):48-60. PubMed ID: 17707360
[TBL] [Abstract][Full Text] [Related]
20. Multidrug Delivery Systems Based on Human Serum Albumin for Combination Therapy with Three Anticancer Agents.
Qi J; Zhang Y; Gou Y; Lee P; Wang J; Chen S; Zhou Z; Wu X; Yang F; Liang H
Mol Pharm; 2016 Sep; 13(9):3098-105. PubMed ID: 27453125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
